Advertisement
Singapore markets closed

  • Straits Times Index

    3,272.72
    +47.55 (+1.47%)
     

  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     

  • Dow

    38,239.98
    +253.58 (+0.67%)
     

  • Nasdaq

    15,451.31
    +169.30 (+1.11%)
     

  • Bitcoin USD

    65,979.42
    +124.82 (+0.19%)
     

  • CMC Crypto 200

    1,420.60
    +5.84 (+0.41%)
     

  • FTSE 100

    8,052.39
    +28.52 (+0.36%)
     

  • Gold

    2,315.70
    -30.70 (-1.31%)
     

  • Crude Oil

    81.35
    -0.55 (-0.67%)
     

  • 10-Yr Bond

    4.6230
    +0.0080 (+0.17%)
     

  • Nikkei

    37,552.16
    +113.55 (+0.30%)
     

  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     

  • FTSE Bursa Malaysia

    1,561.64
    +2.05 (+0.13%)
     

  • Jakarta Composite Index

    7,110.81
    +36.99 (+0.52%)
     

  • PSE Index

    6,506.80
    +62.72 (+0.97%)
     

Allscripts Expands Partnership With PIH Health Through 2025

Zacks Equity Research

Allscripts Healthcare Solutions, Inc. MDRX recently announced the expansion of an agreement with PIH Health through 2025. This is likely to improve comprehensive care for Allscripts’ patient communities.

Following the release, shares of the Zacks Rank #4 (Sell) company rose 1.9% to $9.65 at close.

For investors’ notice, California-based PIH Health is a fully integrated, nonprofit, regional healthcare delivery network comprised of three hospitals, a host of outpatient medical offices, and a multi-specialty medical group, including home health and hospice care.

How Will Allscripts Gain?

Since 2004, PIH Health has been using Allscripts’ solutions, which include the flagship Sunrise EHR platform, the Allscripts TouchWorks EHR platform and the Allscripts CareInMotion population health suite. This extension signifies the expansion in the use and demand for Allscripts’ EHR platforms.

ADVERTISEMENT

Notably, Allscripts’ solutions will also be extended to its newly-acquired PIH Good Samaritan Hospital.

Other Developments in EHR Platform

Allscripts has seen some developments in its EHR platform of late.

In January, the company announced the extension of its engagement with Northwell Health, New York State’s largest health system. Per terms of the agreement, the use of Allscripts’ EHR platforms — Sunrise and TouchWorks — will be implemented by Northwell’s physicians.

That’s not all. In 2019, the companies announced plans to jointly develop a next-generation EHR platform.

Last December, Allscripts’ client, Wyckoff Heights Medical Center, went live with its use of Sunrise platform, which included Sunrise Acute Care, Sunrise Revenue Cycle, Sunrise Radiology, Sunrise HIM and Sunrise Pharmacy.

Earlier, the company’s Sunrise Community Care suite was selected by San Gorgonio Memorial Hospital. (Read More: San Gorgonio Hospital Picks Allscripts Sunrise Community Care)

Strong Preliminary Q4 Results

Reflective of a plethora of developments in its EHR platform, Allscripts announced strong fourth-quarter 2019 preliminary results.

Notably, the company expects bookings within $1,090-$1,110 million, suggesting an increase from the prior outlook of $1,050-$1,100 million.

Reported and adjusted revenues for the quarter are expected between $450 million and $455 million.

 

Price Performance

We believe that positive developments such as these will provide some cushion to Allscripts which has declined 17.3% against the industry’s 21.9% rally in a year’s time.

Key Picks

Some better-ranked stocks in the broader medical space are Cerner Corporation CERN, DexCom DXCM and HealthEquity HQY. While HealthEquity sports a Zacks Rank #1 (Strong Buy), Cerner and DexCom carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Cerner’s long-term earnings growth rate is estimated at 13.6%.

DexCom’s fourth-quarter earnings growth rate is projected at 31.5%.

HealthEquity’s long-term earnings growth rate is pegged at 25%.

Free: Zacks’ Single Best Stock Set to Double

Today you are invited to download our latest Special Report that reveals 5 stocks with the most potential to gain +100% or more in 2020. From those 5, Zacks Director of Research, Sheraz Mian hand-picks one to have the most explosive upside of all.

This pioneering tech ticker had soared to all-time highs and then subsided to a price that is irresistible. Now a pending acquisition could super-charge the company’s drive past competitors in the development of true Artificial Intelligence. The earlier you get in to this stock, the greater your potential gain.

See 5 Stocks Set to Double>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Allscripts Healthcare Solutions, Inc. (MDRX) : Free Stock Analysis Report
 
Cerner Corporation (CERN) : Free Stock Analysis Report
 
DexCom, Inc. (DXCM) : Free Stock Analysis Report
 
HealthEquity, Inc. (HQY) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.